Robert William Gibson

Augusta University

$3,604,829

Attributed

$6,569,400

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2009–21

$2M$1.5M$1M$500K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$13,377,746 · 4

By mechanism

P20$8,358,349 · 3

U01$5,019,397 · 1

Top collaborators

Abdullah Kutlar20 shared

Most similar at Augusta University

Same institution · by research overlap

Abdullah Kutlar$13,235,740

Others in their field

Top investigators on “Caring”

Sonia M Thomas · Research Triangle Institute$700,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$279,179,778
Chanza Baytop · Westat, Inc.$271,217,917
Larry Arthur$256,720,406

Research focus

CaringSickle CellProviderPainAdultMedicalSickle Cell AnemiaBaseChronicUniversitiesChronic PainSiteFocus GroupsCommunitiesChildhoodEffective TherapyResponseHome EnvironmentHealthcareHospitalizationEvidence BasePatient OrientedAcuteAdolescent

Grant awards (25)

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$630,493

U01 · FY2021 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$176,603

U01 · FY2021 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$104,807

U01 · FY2021 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$912,872

U01 · FY2020 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$28,547

U01 · FY2020 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$27,519

U01 · FY2020 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$923,745

U01 · FY2019 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$923,745

U01 · FY2018 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$624,658

U01 · FY2017 · HL

Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease$666,408

U01 · FY2016 · HL

NCMHD Southeastern Exploratory Sickle Cell Center of Excellence$1,274,264

P20 · FY2013 · MD

Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in$70,079

P20 · FY2013 · MD

Community Engagement/Outreach Core$41,066

P20 · FY2013 · MD · contact PI

NCMHD Southeastern Exploratory Sickle Cell Center of Excellence$1,371,402

P20 · FY2012 · MD

Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in$280,350

P20 · FY2012 · MD

Community Engagement/Outreach Core$280,350

P20 · FY2012 · MD · contact PI

NCMHD Southeastern Exploratory Sickle Cell Center of Excellence$1,371,881

P20 · FY2011 · MD

Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in$184,395

P20 · FY2011 · MD

Community Engagement/Outreach Core$105,255

P20 · FY2011 · MD · contact PI

NCMHD Southeastern Exploratory Sickle Cell Center of Excellence$1,372,287

P20 · FY2010 · MD

Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in$183,505

P20 · FY2010 · MD

Community Engagement/Outreach Core$106,004

P20 · FY2010 · MD · contact PI

NCMHD Southeastern Exploratory Sickle Cell Center of Excellence$1,418,512

P20 · FY2009 · MD

Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in$191,417

P20 · FY2009 · MD

Community Engagement/Outreach Core$107,582

P20 · FY2009 · MD · contact PI